312 related articles for article (PubMed ID: 26185208)
1. Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?
Sanina C; Hare JM
Circ Res; 2015 Jul; 117(3):229-33. PubMed ID: 26185208
[TBL] [Abstract][Full Text] [Related]
2. Adipose-derived Mesenchymal Stem Cells and Their Reparative Potential in Ischemic Heart Disease.
Badimon L; Oñate B; Vilahur G
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):599-611. PubMed ID: 26028258
[TBL] [Abstract][Full Text] [Related]
3. [Regenerative treatment of advanced heart disease].
Leistner DM; Seeger FH; Dimmeler S; Zeiher AM; Assmus B
Dtsch Med Wochenschr; 2012 Apr; 137(14):732-7. PubMed ID: 22454205
[No Abstract] [Full Text] [Related]
4. Regenerative medicine techniques in cardiovascular disease: where is the horizon?
Packer C; Boddice B; Simpson S
Regen Med; 2013 May; 8(3):351-60. PubMed ID: 23627828
[TBL] [Abstract][Full Text] [Related]
5. [Regenerative therapy in cardiology].
Chatterjee T; Ortak J; Akin I; Adolph E; Kleinfeldt T; Kische S; Nienaber CA; Ince H
Praxis (Bern 1994); 2009 Mar; 98(6):321-9. PubMed ID: 19291639
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic mesenchymal precursor cells (MPCs): an innovative approach to treating advanced heart failure.
Westerdahl DE; Chang DH; Hamilton MA; Nakamura M; Henry TD
Expert Opin Biol Ther; 2016 Sep; 16(9):1163-9. PubMed ID: 27376188
[TBL] [Abstract][Full Text] [Related]
7. Clinical study using adipose-derived mesenchymal-like stem cells in acute myocardial infarction and heart failure.
Panfilov IA; de Jong R; Takashima S; Duckers HJ
Methods Mol Biol; 2013; 1036():207-12. PubMed ID: 23807797
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart.
Emmert MY; Wolint P; Winklhofer S; Stolzmann P; Cesarovic N; Fleischmann T; Nguyen TD; Frauenfelder T; Böni R; Scherman J; Bettex D; Grünenfelder J; Schwartlander R; Vogel V; Gyöngyösi M; Alkadhi H; Falk V; Hoerstrup SP
Biomaterials; 2013 Mar; 34(10):2428-41. PubMed ID: 23332174
[TBL] [Abstract][Full Text] [Related]
9. [Phase III clinical trial using autologous mesenchymal stem cells for stroke patients].
Honmou O
Nihon Rinsho; 2016 Apr; 74(4):649-54. PubMed ID: 27333754
[TBL] [Abstract][Full Text] [Related]
10. Mass Customized Outlook for Regenerative Heart Failure Care.
Yamada S; Bartunek J; Behfar A; Terzic A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768825
[TBL] [Abstract][Full Text] [Related]
11. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
[TBL] [Abstract][Full Text] [Related]
12. The current status of stem cell therapy in ischemic heart disease.
Michler RE
J Card Surg; 2018 Sep; 33(9):520-531. PubMed ID: 30136308
[TBL] [Abstract][Full Text] [Related]
13. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy.
Chin SP; Poey AC; Wong CY; Chang SK; Teh W; Mohr TJ; Cheong SK
Cytotherapy; 2010; 12(1):31-7. PubMed ID: 19878080
[TBL] [Abstract][Full Text] [Related]
14. Current status of intramyocardial bone marrow stem cell transplantation.
Kaminski A; Steinhoff G
Semin Thorac Cardiovasc Surg; 2008; 20(2):119-25. PubMed ID: 18707644
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology for mesenchymal stem cell therapies.
Corradetti B; Ferrari M
J Control Release; 2016 Oct; 240():242-250. PubMed ID: 26732556
[TBL] [Abstract][Full Text] [Related]
16. [Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications].
Centola M; Schuleri KH; Lardo AC; Hare JM
G Ital Cardiol (Rome); 2008 Apr; 9(4):234-50. PubMed ID: 18543793
[TBL] [Abstract][Full Text] [Related]
17. Meeting report: Adult Mesenchymal Stem Cells in Regenerative Medicine conference, August 2007.
Rao M
Stem Cells; 2007 Nov; 25(11):2973-4. PubMed ID: 17885075
[No Abstract] [Full Text] [Related]
18. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
[TBL] [Abstract][Full Text] [Related]
19. Current outlook of cardiac stem cell therapy towards a clinical application.
Takashima S; Tempel D; Duckers HJ
Heart; 2013 Dec; 99(23):1772-84. PubMed ID: 23525708
[No Abstract] [Full Text] [Related]
20. Treating heart disease with stem cells. Novel therapy holds promise for victims of heart attack and heart failure.
Duke Med Health News; 2008; Suppl():4-5. PubMed ID: 18998607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
